Detalhe da pesquisa
1.
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.
EClinicalMedicine
; 68: 102383, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38545090
2.
Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza.
Open Forum Infect Dis
; 6(4): ofz163, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31041358
3.
Pathology case of the month. 41-year-old woman with abdominal discomfort and weight loss.
J La State Med Soc
; 156(4): 177-80, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15366344